Cystic fibrosis (CF) treatment with comprehensive management of adults with CF and the option to participate in early phase trials for novel CF focused therapies.
Cystic fibrosis is often caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
The CFTR gene provides instructions for making a protein called the cystic fibrosis transmembrane conductance regulator.
Interstitial lung disease service that provides assistance for the diagnosis and therapy of a variety of lung diseases
Pulmonary rehabilitation service to improve lung function and promote a healthy lifestyle for patients with:
A mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
